← Back to Search

Mobile App Training for Impulsivity (DelTA Trial)

N/A
Recruiting
Led By Julie Schweitzer, Ph.D.
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 3-6 years
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 weeks
Awards & highlights

DelTA Trial Summary

This trial is testing if a mobile app can help increase self-control in children by using computerized game time as a reward.

Who is the study for?
This trial is for preschool-aged children (3-6 years old) who show high levels of impulsivity, as indicated by specific rating scales. They must be physically and visually able to use a tablet and if on medication, keep the same type throughout the study.Check my eligibility
What is being tested?
The study tests whether self-control in highly impulsive young children can be improved using mobile app games that reward them for waiting longer times for better rewards. It builds on earlier work showing success with non-digital games.See study design
What are the potential side effects?
Since this intervention involves behavioral training through games, there are no direct medical side effects. However, increased screen time could potentially affect sleep patterns or behavior.

DelTA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 3 and 6 years old.

DelTA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Indifference point
Percent change in preference for longer, larger (LL) rewards
Secondary outcome measures
ADHD-RS-IV Preschool Version and Attention and Behavior Rating Form
Dinky Toy Task
Gift Wrap and Gift Delay Task
+3 more

DelTA Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TreatmentExperimental Treatment1 Intervention
Participants in the Experimental arm will begin the Shaping Delay Tolerance behavioral intervention immediately after baseline, and this training will last for about 6 weeks.
Group II: Wait-list ControlActive Control1 Intervention
After baseline, participants in the Wait-list Control arm will wait for about 6-weeks before entering the pre-treatment phase, which is a repeat of effortful control assessments and behavior questionnaires, and then they will begin training for with the Shaping Delay Tolerance behavioral intervention.

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
909 Previous Clinical Trials
4,704,080 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,953 Previous Clinical Trials
2,660,430 Total Patients Enrolled
Julie Schweitzer, Ph.D.Principal InvestigatorUC Davis MIND Institute
1 Previous Clinical Trials
109 Total Patients Enrolled

Media Library

Shaping Delay Tolerance Clinical Trial Eligibility Overview. Trial Name: NCT03457402 — N/A
Impulsivity Research Study Groups: Treatment, Wait-list Control
Impulsivity Clinical Trial 2023: Shaping Delay Tolerance Highlights & Side Effects. Trial Name: NCT03457402 — N/A
Shaping Delay Tolerance 2023 Treatment Timeline for Medical Study. Trial Name: NCT03457402 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are permitted to enroll in this clinical experiment?

"Affirmative, the information available on clinicaltrials.gov suggests that this medical trial is still recruiting patients. The trial was inaugurated September 12th 2017 and its latest update occurred May 10th 2022; it requires 50 volunteers from a single centre."

Answered by AI

Are there still spaces available for participants in this clinical experiment?

"Affirmative, the information on clinicialtrials.gov verifies that registration is open for this investigation. The trial was initially posted in September of 2017 and last updated in May 2022; 50 patients need to be recruited from a single research site."

Answered by AI

Am I eligible to participate in this experiment?

"To be eligible for this trial, participants must display signs of impetuosity and have attained the age between 3 to 6. As of now, there are openings available for 50 candidates."

Answered by AI

What outcomes is this trial hoping to accomplish?

"This clinical trial's primary outcome, which will be assessed within 6 weeks is the Indifference point. Secondary objectives include The Preschool Life Skills Questionnaire (a 13-item teacher scale that measures instruction following, functional communication, delay tolerance and friendship skills), ADHD-RS-IV Preschool Version and Attention and Behavior Rating Form (parent/teacher ratings regarding inattentive/hyperactivity impulsivity) as well as Gift Wrap and Gift Delay Task (an assessment of effortful control). Researchers anticipate the shaping group to have better improvement with regards to parent/teacher ratings on impulsivity, effortful control and delay tolerance compared to"

Answered by AI

Is this trial actively searching for participants aged fifty or older?

"To be eligible for this medical trial, participants must have a chronological age between 3 and 6 years. Additionally, there are 4 specific trials available to patients under the legal age of consent and an additional 6 studies targeting adults over 65."

Answered by AI
Recent research and studies
~1 spots leftby May 2024